Neurology
 |
|
15 february 2021 20:27:57 |
| Rivaroxaban for the treatment of cerebral venous thrombosis (BMC Neurology) |
|
Tweet New Oral Anticoagulants (NOACs) such as Rivaroxaban are introduced as alternatives to conventional vitamin-K antagonists in the long-term treatment of thrombotic events due to their lower bleeding risk. There ... |
| 216 viewsCategory: Neurology |
 Clinical features with anti fibroblast growth factor receptor 3 (FGFR3) antibody-related polyneuropathy: a retrospective study (BMC Neurology)Proteomic insights into synaptic signaling in the brain: the past, present and future (Molecular Brain) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
